EG-VEGF Antibodies

Santa Cruz Biotechnology delivers a wide array of EG-VEGF monoclonal antibodies for research in understanding this important protein's role. EG-VEGF monoclonal antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EG-VEGF, or endothelial growth factor B, is a key player in angiogenesis, particularly in the development of the vascular system in the placenta. It is primarily expressed in the placenta and has been implicated in various physiological and pathological processes, including tumor growth and metastasis. Understanding the function of EG-VEGF is crucial for developing therapeutic strategies targeting vascular-related diseases. EG-VEGF monoclonal antibodies enable detailed investigation of molecular pathways involved in placental development and vascular formation. Researchers studying angiogenesis mechanisms can utilize EG-VEGF monoclonal antibodies to uncover new insights about vascular system development. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of vascular biology and disease mechanisms.